Benefit associated with appropriate antibiotic treatment

Clinical Infectious Diseases

Volumn 45, Issue 10, 2007, Pages 1400-

  Leibovici, Leonard ^a,b,c   Paul, Mical ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Beilinson Campus ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTEREMIA; COST EFFECTIVENESS ANALYSIS; HUMAN; LETTER; MEDICAL ETHICS; MORTALITY; PRIORITY JOURNAL; SEPSIS; HEALTH SERVICES RESEARCH; METHODOLOGY; NOTE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; HEALTH SERVICES RESEARCH; HUMANS; TREATMENT OUTCOME;

EID: 36048930578     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522772     Document Type: Letter

References (11)

1. McGregor JC, Rich SE, Harris AD, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007; 45:329-37.
2. Leibovici L, Shraga I, Andreassen S. How do you choose antibiotic treatment? BMJ 1999; 318:1614-8.
3. Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome? Clin Infect Dis 2007; 44:87-93.
4. Pazos Anon R, Fernandez Rodriguez R, Paz Vidal I, et al. Antimicrobial susceptibility of the bloodstream infections: a study in a nonteaching hospital. An Med Interna 2004; 21:483-7.
5. Hanon FX, Monnet DL, Sorensen TL, et al. Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis 2002; 34:520-8.
6. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-86.
7. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123:1615-24.
8. Jamulitrat S, Meknavin U, Thongpiyapoom S. Factors affecting mortality outcome and risk of developing nosocomial bloodstream infection. Infect Control Hosp Epidemiol 1994; 15:163-70.
9. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-35.
10. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31:2742-51.
11. Leibovici L, Drucker M, Konigsberger H, et al. Septic shock in bacteremic patients: risk factors, features and prognosis. Scand J Infect Dis 1997; 29:71-5.